Polkadot vs Mira — how do they compare? Polkadot trades at Rp13,583 (market cap Rp23,11T, Rp827,91M 24h volume), while Mira trades at Rp701.98 (market cap Rp224,09M, Rp101,31M 24h volume). The key difference: Polkadot is far larger — about 103128.2× Mira's market cap, and Polkadot's circulating supply is 1,7B / 2,1B DOT (81%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold Polkadot for 118 Days and Mira for 22 Days on average.
| DOT | MIRA | |
|---|---|---|
Market Cap | Rp23,11T | Rp224,09M |
Volume (24h) | Rp827,91M | Rp101,31M |
Circulating Supply | 1,7B / 2,1B DOT (81%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 118 Days | 22 Days |
Signals from Pluang's Aura AI — not financial advice
Polkadot is currently trading at Rp13,557 with a bearish technical signal as moving averages show strong selling pressure while oscillators remain neutral. The token trades near key support at S3=13,542 IDR with RSI_6 at 8.71 indicating potential oversold conditions. With 81% of max supply in circulation and average hold time of 118 days, the network maintains steady token distribution despite current market weakness.
Overall outlook remains cautious with technical indicators favoring sellers, though oversold RSI suggests potential near-term bounce. Key opportunities include protocol's interoperability focus and established ecosystem, while risks include continued bearish momentum and crypto market volatility. Investors should monitor support levels closely.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
What Pluang investors did over the last 30 days
Latest headlines on both assets
A crypto asset founded by Gavin Wood (a co-founder of Ethereum) alongside co-founders Peter Czaban and Robert Habermeier in 2016. It was finally launched in 2020 with the goal of incentivizing the global network of computers to use blockchain for its operation which users can launch and operate their own blockchains system.
Read more on DOT →Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →